Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen

Molecular Cancer Therapeutics

Volumn 5, Issue 10, 2006, Pages 2468-2473

  Christiansen, Jason J ^a   Weimbs, Thomas ^b   Bander, Neil ^c   Rajasekaran, Ayyappan K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC MEMBRANE ANTIGEN; SNARE PROTEIN; SYNTAXIN; SYNTAXIN 3; UNCLASSIFIED DRUG; VINBLASTINE;

ANIMAL CELL; ANTIGEN EXPRESSION; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CANCER IMMUNOTHERAPY; CELL POLARITY; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DEPOLYMERIZATION; DRUG TARGETING; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY CELL; MALE; MICROTUBULE ASSEMBLY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN LOCALIZATION; PROTEIN TARGETING; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CELL MEMBRANE; DOGS; EPITHELIUM; HUMANS; KIDNEY; MALE; MICROTUBULES; NOCODAZOLE; POINT MUTATION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; QA-SNARE PROTEINS; TAXOIDS; TUBULIN MODULATORS; VINBLASTINE;

EID: 33750449627     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0253     Document Type: Article

References (40)

1. Chang SS, Heston WD. The clinical role of prostate-specific membrane antigen (PSMA). Urol Oncol 2002;7:7-12.
2. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-35.
3. Israeli RS, Powell CT, Fair WR, Heston WD. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993;53:227-30.
4. Ross JS, Sheehan CE, Fisher HA, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 2003;9:6357-62.
5. Holmes EH. PSMA specific antibodies and their diagnostic and therapeutic use. Expert Opin Investig Drugs 2001;10:511-9.
6. Nanus DM, Milowsky MI, Kostakoglu L, et al. Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. J Urol 2003;170:S84-8; discussion S88-9.
7. Lopes AD, Davis WL, Rosenstraus MJ, Uveges AJ, Gilman SC. Immumohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-5. Cancer Res 1990;50:6423-9.
8. Rosenthal SA, Haseman MK, Polascik TJ. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer. Tech Urol 2001;7:27-37.
9. McDevitt MR, Barendswaard E, Ma D, et al. An α-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res 2000;60:6095-100.
10. Ballangrud AM, Yang WH, Chariton DE, et al. Response of LNCaP spheroids after treatment with an α-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591). Cancer Res 2001; 61:2008-14.
11. Bander NH, Trabulsi EJ, Kostakoglu L, et al. Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol 2003;170:1717-21.
12. Fracasso G, Bellisola G, Cingarlini S, et al. Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. Prostate 2002; 53:9-23.
13. Christiansen JJ, Rajasekaran AK. Biological impediments to monoclonal antibody-based cancer immunotherapy. Mol Cancer Ther 2004;3:1493-501.
14. Christiansen JJ, Rajasekaran SA, Inge L, et al. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther 2005;4:704-14.
15. Zegers MM, Zeal KJ, van Ijzendoorn SC, Klappe K, Hoekstra D. Actin filaments and microtubules are involved in different membrane traffic pathways that transport sphingolipids to the apical surface of polarized HepG2 cells. Mol Biol Cell 1998;9:1939-49.
16. Tai AW, Chuang JZ, Sung CH. Cytoplasmic dynein regulation by subunit heterogeneity and its role in apical transport. J Cell Biol 2001;153: 1499-509.
17. Chen YA, Scheller RH. SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol 2001;2:98-106.
18. Hu C, Ahmed M, Melia TJ, Sollner TH, Mayer T, Rothman JE. Fusion of cells by flipped SNAREs. Science 2003;300:1745-9.
19. McNew JA, Parlati F, Fukuda R, et al. Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature 2000;407: 153-9.
20. Low SH, Chapin SJ, Weimbs T, Komuves LG, Bennett MK, Mostov KE. Differential localization of syntaxin isoforms in polarized Madin-Darby canine kidney cells. Mol Biol Cell 1996;7:2007-18.
21. Low SH, Chapin SJ, Wimmer C, et al, The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells. J Cell Biol 1998;141:1503-13.
22. Scales SJ, Chen YA, Yoo BY, Patel SM, Doung YC, Scheller RH. SNAREs contribute to the specificity of membrane fusion. Neuron 2000; 26:457-64.
23. Sharma N, Low SH, Misra S, Pallavi B, Weimbs T. Apical targeting of syntaxin 3 is essential for epithelial cell polarity. J Cell Biol 2006;173: 937-48.
24. Rajasekaran AK, Humphrey JS, Wagner M, et al. TGN38 recycles basolaterally in polarized Madin-Darby canine kidney cells. Mol Biol Cell 1994;5:1093-103.
25. Liu H, Moy P, Kim S, et al. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 1997;57:3629-34.
26. Li X, Low SH, Miura M, Weimbs T. SNARE expression and localization in renal epithelial cells suggest mechanism for variability of trafficking phenotypes. Am J Physiol Renal Physiol 2002;283:F1111-22.
27. Weimbs T, Low SH, Li X, Kreitzer G. SNAREs and epithelial cells. Methods 2003;30:191-7.
28. Imai A, Nashida T, Yoshie S, Shimomura H. Intracellular localisation of SNARE proteins in rat parotid acinar cells: SNARE complexes on the apical plasma membrane. Arch Oral Biol 2003;48:597-604.
29. Fujita H, Tuma PL, Finnegan CM, Locco L, Hubbard AL. Endogenous syntaxins 2, 3 and 4 exhibit distinct but overlapping patterns of expression at the hepatocyte plasma membrane. Biochem J 1998;329:527-38.
30. Delgrossi MH, Breuza L, Mirre C, Chavrier P, Le Bivic A. Human syntaxin 3 is localized apically in human intestinal cells. J Cell Sci 1997; 110:2207-14.
31. Christiansen JJ, Rajasekaran SA, Moy P, et al. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate 2003;55:9-19.
32. Low SH, Vasanji A, Nanduri J, et al. Syntaxins 3 and 4 are concentrated in separate clusters on the plasma membrane before the establishment of cell polarity. Mol Biol Cell 2006;17:977-89.
33. Kreitzer G, Schmoranzer J, Low SH, et al. Three-dimensional analysis of post-Golgi carrier exocytosis in epithelial cells. Nat Cell Biol 2003;5: 126-36.
34. Koletsky AJ, Guerra ML, Kronish L. Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer. Cancer J 2003;9:286-92.
35. Oudard S, Caty A, Humblet Y, et al. Phase II study of vinorelbine in patients with androgen-independent prostate cancer. Ann Oncol 2001;12: 847-52.
36. Khawli LA, Miller GK, Epstein AL. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors. Cancer 1994;73:824-31.
37. Shelly M, Mosesson Y, Citri A, et al. Polar expression of ErbB-2/HER2 in epithelia. Bimodal regulation by Lin-7. Dev Cell 2003;5:475-86.
38. Wilson PD. Epithelial cell polarity and disease. Am J Physiol 1997; 272:F434-42.
39. Stein M, Wandinger-Ness A, Roitbak T. Altered trafficking and epithelial cell polarity in disease. Trends Cell Biol 2002;12:374-81.
40. Su Q, Cai Q, Gerwin C, Smith CL, Shang ZH. Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons. Nat Cell Biol 2004;6:941-53.